Profile
| Metric | Value |
|---|---|
| Full Name | Tempest Therapeutics, Inc. |
| Ticker | NASDAQ: TPST |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | tempesttx.com |
| Employees | 24 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $2.81 | |
| Price, 1D Change | -0.35% | |
| $10M | ||
| - | ||
| - | ||
| 1.61 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$19.50 | ||
| EPS, 1Y Change | -919.11% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:13 | |
| Next Split | N/A | N/A |
| Last Ticker Change | MLND | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$19.50 | ||
| EPS Estimate | - | |
| EPS Est. Change | - | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $2.81 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$1.93 | -$1.91 | +0.88% | |
| -$1.32 | -$19.50 | -1,382.56% | |
| - | N/A | - | |
| -$16.02 | N/A | +17.83% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $2.81 | |
| $7.61 | ||
| SMA 200 vs Price | +170.98% | |
| $5.41 | ||
| SMA 50 vs Price | +92.67% | |
| 1.61 | ||
| $0.27 | ||
| 28.35 | ||
| 36.65% | ||
| 98.64% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$19.50 | ||
| -$389.00K | ||
| - | ||
| -$42.03M | ||
| - | ||
| -$41.84M | ||
| - | ||
| -$41.64M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.80 | ||
| 2.21 | ||
| 2.21 | ||
| - | ||
| - | ||
| -9.02 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 1.63 | ||
| -0.31 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $19.13M | ||
| $30.27M | ||
| $44.03M | ||
| $31.47M | ||
| $24.90M | ||
| $14.22M | ||
| $15.37M | ||
| $7.22M | ||
| $2.45M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $41.84M | ||
| $41.64M | ||
| $389.00K | ||
| $0.00 | ||
| $389.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$33.03M | ||
| -$435.00K | ||
| $24.50M | ||
| $435.00K | ||
| -$33.46M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Scotiabank | → | |
| HC Wainwright & Co. | → | |
| Scotiabank | → | |
| HC Wainwright & Co. | → | |
| Piper Sandler | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Piper Sandler | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with TPST
Data Sources & References
- TPST Official Website www.tempesttx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1544227/000119312525265946/0001193125-25-265946-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1544227/000095017025046144/0000950170-25-046144-index.htm
- TPST Profile on Yahoo Finance finance.yahoo.com/quote/TPST
- TPST Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/tpst
FAQ
What is the ticker symbol for Tempest Therapeutics, Inc.?
The ticker symbol for Tempest Therapeutics, Inc. is NASDAQ:TPST
Does Tempest Therapeutics, Inc. pay dividends?
No, Tempest Therapeutics, Inc. does not pay dividends
What sector is Tempest Therapeutics, Inc. in?
Tempest Therapeutics, Inc. is in the Healthcare sector
What industry is Tempest Therapeutics, Inc. in?
Tempest Therapeutics, Inc. is in the Biotechnology industry
What country is Tempest Therapeutics, Inc. based in?
Tempest Therapeutics, Inc. is headquartered in United States
When did Tempest Therapeutics, Inc. go public?
Tempest Therapeutics, Inc. initial public offering (IPO) was on November 12, 2012
Is Tempest Therapeutics, Inc. in the S&P 500?
No, Tempest Therapeutics, Inc. is not included in the S&P 500 index
Is Tempest Therapeutics, Inc. in the NASDAQ 100?
No, Tempest Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Tempest Therapeutics, Inc. in the Dow Jones?
No, Tempest Therapeutics, Inc. is not included in the Dow Jones index
When was Tempest Therapeutics, Inc. last earnings report?
Tempest Therapeutics, Inc.'s most recent earnings report was on November 5, 2025
When does Tempest Therapeutics, Inc. report earnings?
The next expected earnings date for Tempest Therapeutics, Inc. is March 26, 2026